Basic information Safety Related Supplier
ChemicalBook >  Product Catalog >  API >  Antineoplastic agents >  Natural sources of antineoplastic >  Trastuzumab

Trastuzumab

Basic information Safety Related Supplier
Trastuzumab Basic information
Trastuzumab Usage And Synthesis
  • IndicationsThe introduction of herceptin (Trastuzumab) into clinical practice for the treatment of breast cancer marks a major advance in the use of monoclonal antibody cancer therapy. Herceptin is a humanized antibody directed against the HER-2 antigen that is overexpressed on the tumor cell surface in approximately 25% of breast cancer patients. HER-2/neu/erbB2 overexpression marks an aggressive estrogen receptor–negative form of breast cancer. Therefore, a therapeutic agent selective for this target is particularly valuable. Herceptin is administered by intravenous infusion and in conjunction with paclitaxel can extend survival in patients with HER-2/neu/erbB2 overexpressing metastatic breast cancer.Herceptin use is associated with infusion- related hypotension, flushing and bronchoconstriction, and skin rash but no bone marrow toxicity. Herceptin appears to sensitize patients to cardiotoxicity, an important concern in patients also receiving doxorubicin.
Trastuzumab(180288-69-1)Related Product Information
TrastuzumabSupplierMore
  • Company Name:Chembest Research Laboratories Limited
  • Tel:021-20908456-
  • Email:sales@BioChemBest.com
  •  
  • Company Name:LGM Pharma
  • Tel:1-(800)-881-8210
  • Email:inquiries@lgmpharma.com
  •  
  • Company Name:Wuhan Sunrise Technology Development Co., Ltd.
  • Tel:13554138826
  • Email:whsrtech@vip.163.com;whsrtech@vip.163.com
  •  
  • Company Name:Beijing HuaMeiHuLiBiological Chemical
  • Tel:010-56205725
  • Email:waley188@sohu.com
  •  
  • Company Name:Nanjing Duolong Bio-tech Co.,Ltd.
  • Tel:18905173768
  • Email:sales@dolonchem.com
  •